期刊
LIFE SCIENCES
卷 280, 期 -, 页码 -出版社
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.lfs.2021.119744
关键词
Nanoparticles; Polymer; Vaccines; Respiratory viruses; Respiratory tract infections
Viral respiratory tract infections have a significant impact on global health and socio-economic growth, with vaccination being the primary method of prevention. However, traditional vaccines have limitations, prompting the need for novel vaccine delivery vehicles to enhance immune responses. This review explores how polymer-based nanoparticles can be integrated with vaccine development to effectively combat viral respiratory tract infections.
Viral respiratory tract infections have significantly impacted global health as well as socio-economic growth. Respiratory viruses such as the influenza virus, respiratory syncytial virus (RSV), and the recent SARS-CoV-2 infection (COVID-19) typically infect the upper respiratory tract by entry through the respiratory mucosa before reaching the lower respiratory tract, resulting in respiratory disease. Generally, vaccination is the primary method in preventing virus pathogenicity and it has been shown to remarkably reduce the burden of various infectious diseases. Nevertheless, the efficacy of conventional vaccines may be hindered by certain limitations, prompting the need to develop novel vaccine delivery vehicles to immunize against various strains of respiratory viruses and to mitigate the risk of a pandemic. In this review, we provide an insight into how polymer-based nanoparticles can be integrated with the development of vaccines to effectively enhance immune responses for combating viral respiratory tract infections.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据